Metabolic-associated fatty liver disease and the risk of cardiovascular disease-Reference-Cited by-同舟云学术

Metabolic-associated fatty liver disease and the risk of cardiovascular disease

Published:2023-01 Issue:1 Volume:47 Page:102063
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Zhang Pengwei,Dong Xianhui,Zhang Wei,Wang Shiyin,Chen Chen,Tang Jiake,You Yao,Hu Siqi,Zhang Shenghui,Wang Chunyi,Wen Wen,Zhou Mengyun,Tan Tao,Qi Guanming,Li Li,Wang Mingwei^ORCID

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference42 articles.

1. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement;Eslam;J Hepatol,2020

2. Global multi-stakeholder consensus on the redefinition of fatty liver disease. Global multi-stakeholder endorsement of the MAFLD definition;Méndez-Sánchez;Lancet Gastroenterol Hepatol,2022

3. International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease;Eslam;Gastroenterology,2020

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

5. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease;Eslam;Hepatol Int,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of high cardiovascular risk in patients with nonalcoholic fatty liver disease;Consilium Medicum;2024-08-05

2. Prevalence of Cardiovascular Disease (CAD) due to industrial air pollutants in the proximity of Islamabad Industrial Estate (IEI), Pakistan;PLOS ONE;2024-07-17

3. Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions;Nutrients;2024-07-11

4. Network Pharmacology and Molecular Docking Integrated with Molecular Dynamics Simulations Investigate the Pharmacological Mechanism of Yinchenhao Decoction in the Treatment of Non-alcoholic Fatty Liver Disease;Current Computer-Aided Drug Design;2024-07-11

5. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge;Metabolism and Target Organ Damage;2024-06-26